BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.
A new, accurate imaging technique, combining photoacoustics with nanosensors, has been developed for the noninvasive screening of lymph nodes for metastatic cancer.
Preoperative navigated transcranial magnetic stimulation (nTMS) analysis of motor areas can improve the prognosis for patients with malignant brain tumors.
PET-CT guided active surveillance for patients with locally advanced head and neck squamous cell cancer is an option over node dissection, per analysis data presented at the 2015 American Society of Clinical Oncology annual meeting.
Magnetic resonance imaging (MRI) can provide vital information for predicting the odds of breast cancer development.
Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study.
Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.
Although FDG PET/CT is appropriate for systemic staging of newly diagnosed stage III breast cancer, the technique may not be equally valuable for all breast cancer histologies, research indicates.
A magnetic resonance imaging (MRI)-based screening program for persons at high risk of pancreatic cancer identified pancreatic lesions in 40% of patients, according to an online report.
For men with nonmetastatic castration resistant prostate cancer with a negative bone scan after diagnosis, factors associated with a second bone scan include higher PSA, shorter PSA doubling time, and faster PSA velocity; but under- and over-imaging may also be a factor.
Study data suggests that magnetic resonance imaging (MRI) could one day make biopsies more effective, or even replace them altogether, via noninvasive detection of telltale sugar molecules shed by the outer membranes of cancerous cells.
Present barriers for the usual dosimetry accompanying photodynamic therapy (PDT) for late-stage pancreatic cancer can be overcome via clinical technologies.
When low-dose computed tomography is used for second and subsequent lung cancer screening, the rate of repeating early repeat scans for suspicious findings decreased by more than 80%.
Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)April 01, 2015
The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.
An association of high rates of inappropriate imaging for prostate cancer and breast cancer found in a study of Medicare beneficiaries suggests that regional culture could contribute to inappropriate imaging.
Detection of asymptomatic thyroid nodules has increased, and the majority of benign thyroid nodules examined did not lead to a diagnosis of thyroid cancer, according to a recent study.
Magnetic resonance spectroscopy (MRS) shows precancerous breast changes in women with BRCA gene mutationMarch 16, 2015
MRS that incorporates monitoring of biochemical changes in tissue could improve the management of women at risk of breast cancer, according to a new study.
Research indicates a high value of scans that could lead to future change of reimbursement policies for follow-up PET/CT studies in lung cancer.
Not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all underarm nodes removed, new research indicates.
Targeted magnetic resonance (MR)/ultrasound fusion biopsy outperformed standard biopsy technique for increased detection of high-risk prostate cancer, according to a recent study.
Lower use of imaging seen in the VA than in fee-for-service Medicare; not associated with less geographic variation.
A novel medical-imaging technology, TexRAD, which analyzes the texture of tumors, has been shown in trials to enable early diagnosis of colorectal cancer in patients not responding to the standard cancer therapy better than other available tumor markers.
Diffuse optical spectroscopic tomographic imaging (DOST) may be useful in predicting which patients will best respond to chemotherapy used to reduce breast cancer tumors before surgery, according to a new study.
A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.
Positron emission tomography and fludeoxyglucose F18 is less accurate in diagnosing lung cancer from benign disease in areas where histoplasmosis or tuberculosis infections are common.
Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.
The European Journal of Cancer has released a position statement on recent developments in MRI and PET and how these techniques can be used to detect bone metastases.
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
Surgical resection is the most effective method for a cancer cure; however, the procedure may not remove the entire tumor, leading to local recurrence. Researchers at the University of Pennsylvania have established a new strategy in which near-infrared (NIR) imaging is used to help visualize the entire tumor.
Lung cancer patients could receive more precise treatment, and their progress could be better tracked by using a new high-tech method of non-invasive medical imaging analysis, according to a new study.
- Universal health literacy precautions recommended to assist patient understanding
- Likelihood of lung cancer screening update
- Generic meds may boost survival in some early breast cancers
- Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
- New program using CT technology helping to better detect lung cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|